Risk of age-related macular degeneration in men receiving 5α-reductase inhibitors: a population-based cohort study - Su, Yu-Chen; Shen, Chin-Yao; Shao, Shih-Chieh; Lai, Chi-Chun; Hsu, Sheng-Min; Lee, Chaw-Ning; Liu, Chan-Jung; Hung, Jia-Horung; Lai, Edward Chia-Cheng (Age and ageing, 2024)
Keywords: 5-alpha Reductase Inhibitors - adverse effects; 5-alpha Reductase Inhibitors - therapeutic use; Age; Age differences; Aged; Androgens; Cohort analysis; Databases, Factual; Dutasteride - adverse effects; Dutasteride - therapeutic use; Finasteride - adverse effects; Finasteride - therapeutic use; Humans; Hyperplasia; Incidence; Macular degeneration; Macular Degeneration - chemically induced; Macular Degeneration - diagnosis; Macular Degeneration - epidemiology; Male; Middle Aged; National health insurance; Population studies; Propensity; Prostate; Prostatic Hyperplasia - drug therapy; Prostatic Hyperplasia - epidemiology; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity analysis; Steroid 5α-reductase; Taiwan - epidemiology; Tamsulosin - adverse effects; Tamsulosin - therapeutic use; Weighting; Taiwan; 5α-reductase inhibitors; older people; tamsulosin; age-related macular degeneration; benign prostate hyperplasia